Plasma α-melanocyte-stimulating hormone: sex differences and correlations with obesity

Metabolism: Clinical and Experimental

Volumn 58, Issue 1, 2009, Pages 16-21

  Donahoo, William T ^a   Hernandez, Teri L ^a   Costa, Jessica L ^b,c   Jensen, Dalan R ^a   Morris, Alison M ^a   Brennan, Miles B ^b   Hochgeschwender, Ute ^d   Eckel, Robert H ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF DENVER   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA INTERMEDIN; CORTICOTROPIN; GLUCOSE; INSULIN; LEPTIN; LIPID; PROOPIOMELANOCORTIN;

ADDISON DISEASE; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ADOLESCENT; ADULT; AGED; ALPHA-MSH; BLOOD GLUCOSE; BODY COMPOSITION; C-REACTIVE PROTEIN; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; OBESITY; SEX FACTORS; STATISTICS, NONPARAMETRIC; THYROTROPIN; YOUNG ADULT;

EID: 57049164906     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.07.028     Document Type: Article

References (30)

1. Smith S.R. The endocrinology of obesity. Endocrinol Metab Clin North Am. 25 (1996) 921-942
2. Campfield L.A., Smith F.J., Guisez Y., et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 (1995) 546-549
3. Boston B.A., Blaydon K.M., Varnerin J., et al. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278 (1997) 1641-1644
4. Abdel-Malek Z.A. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 58 (2001) 434-441
5. Cone R.D. Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype?. J.Clin Invest 106 (2000) 185-187
6. Fan W., Boston B.A., Kesterson R.A., et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 (1997) 165-168
7. Boston B.A., and Cone R.D. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137 (1996) 2043-2050
8. Mountjoy K.G., Mortrud M.T., Low M.J., et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8 (1994) 1298-1308
9. Chagnon Y.C., Chen W.J., Perusse L., et al. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol Med 3 (1997) 663-673
10. Yaswen L., Diehl N., Brennan M.B., et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5 (1999) 1066-1070
11. Hamilton B.S., and Doods H.N. Chronic application of MTII in a rat model of obesity results in sustained weight loss. Obes Res 10 (2002) 182-187
12. Cettour-Rose P., and Rohner-Jeanrenaud F. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143 (2002) 2277-2283
13. Forbes S., Bui S., Robinson B.R., et al. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci U S A 98 (2001) 4233-4237
14. Butler A.A., Kesterson R.A., Khong K., et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141 (2000) 3518-3521
15. Chen A.S., Marsh D.J., Trumbauer M.E., et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26 (2000) 97-102
16. Katsuki A., Sumida Y., Murashima S., et al. Elevated plasma levels of alpha-melanocyte stimulating hormone (alpha-MSH) are correlated with insulin resistance in obese men. Int.J.Obes.Relat Metab Disord. 24 (2000) 1260-1264
17. Hoggard N., Johnstone A.M., Faber P., et al. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf) 61 (2004) 31-39
18. Gavrila A., Chan J.L., Miller L.C., et al. Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration. J Clin Endocrinol.Metab 90 (2005) 1047-1054
19. Nam S.Y., Kratzsch J., Kim K.W., et al. Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-MSH in obese women and their relationship to negative energy balance. J Clin Endocrinol Metab 86 (2001) 4849-4853
20. Perseghin G., Caumo A., Caloni M., et al. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 86 (2001) 4776-4781
21. Faulkner K.G., and McClung M.R. Quality control of DXA instruments in multicenter trials. Osteoporos Int 5 (1995) 218-227
22. Hochgeschwender U., Costa J.L., Reed P., et al. Altered glucose homeostasis in proopiomelanocortin-null mouse mutants lacking central and peripheral melanocortin. Endocrinology 144 (2003) 5194-5202
23. Schauer E., Trautinger F., Kock A., et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest 93 (1994) 2258-2262
24. Rajora N., Ceriani G., Catania A., et al. alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J Leukoc Biol 59 (1996) 248-253
25. Coates P.J., McNicol A.M., Doniach I., et al. Increased production of alpha-melanocyte-stimulating hormone in the pituitary gland of patients with untreated Addison's disease. Clin Endocrinol (Oxf) 29 (1988) 421-426
26. Silha J.V., Krsek M., Skrha J.V., et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149 (2003) 331-335
27. Melanson E.L., Sharp T.A., Schneider J., et al. Relation between calcium intake and fat oxidation in adult humans. Int J Obes Relat Metab Disord 27 (2003) 196-203
28. Shi H., Dirienzo D., and Zemel M.B. Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J 15 (2001) 291-293
29. Farooqi I.S., Keogh J.M., Yeo G.S., et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348 (2003) 1085-1095
30. Krude H., Biebermann H., Luck W., et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19 (1998) 155-157